









Markets
/
Stocks
/
nasdaq-apyx
/

Apyx Medical Corp

APYX

3.580USD

-0.060-1.65%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

63.10MMarket Cap

LossP/E TTM



Apyx Medical Corp

3.580

-0.060-1.65%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Apyx Medical Corp

Currency: USD Updated: 2026-03-27

Key Insights

Apyx Medical Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 88 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.00.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Apyx Medical Corp's Score

Industry at a Glance

Industry Ranking

88 / 208

Overall Ranking

215 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Apyx Medical Corp Highlights

StrengthsRisks

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Growing

The company is in a growing phase, with the latest annual income totaling USD 52.84M.

Undervalued

The company’s latest PE is -13.34, at a low 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 1.57M shares of this stock.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

6.000

Target Price

+56.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Apyx Medical Corp is 7.83, ranking 56 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 19.16M, representing a year-over-year increase of 34.75%, while its net profit experienced a year-over-year increase of 71.93%.

Score

Industry at a Glance

Previous score

7.83

Change



Financials

6.93

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.91

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.50

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.41

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.42

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Apyx Medical Corp's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Apyx Medical Corp is 6.97, ranking 134 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -13.34, which is -90.76% below the recent high of -1.23 and -9.34% above the recent low of -14.59.

Score

Industry at a Glance

Previous score

6.97

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 88/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Apyx Medical Corp is 7.60, ranking 125 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 5.00, with a high of 8.00 and a low of 4.00.

Score

Industry at a Glance

Previous score

7.60

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

6.000

Target Price

+64.84%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Apyx Medical Corp

APYX

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Apyx Medical Corp is 7.07, ranking 35 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.22 and the support level at 3.03, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.60

Change

-1.53

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.031

Buy

RSI(14)

47.313

Neutral

STOCH(KDJ)(9,3,3)

38.140

Sell

ATR(14)

0.317

Low Volatility

CCI(14)

-75.414

Neutral

Williams %R

72.289

Sell

TRIX(12,20)

0.189

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

3.778

Sell

MA10

3.729

Sell

MA20

3.594

Sell

MA50

3.755

Sell

MA100

3.770

Sell

MA200

3.033

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Apyx Medical Corp is 3.00, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 47.11%, representing a quarter-over-quarter decrease of 12.92%. The largest institutional shareholder is Chuck Royce, holding a total of 2.44M shares, representing 5.84% of shares outstanding, with 12.60% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Nantahala Capital Management, LLC

3.34M

Archon Capital Management LLC

3.28M

Vanderfelt (William Weeks)

3.16M

Royce Investment Partners

Star Investors

2.47M

+1.42%

Vizirgianakis (Stavros G)

1.75M

The Vanguard Group, Inc.

Star Investors

1.53M

+3.60%

Silverberg Bernstein Capital Management, LLC

986.50K

+10.01%

Commonwealth Financial Network

663.54K

Horizon Kinetics LLC

Star Investors

615.00K

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Apyx Medical Corp is 2.99, ranking 134 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.55. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.